EHS
EHS

Antibody Testing in Patients With Neurological and Psychiatric Symptoms

New research may help doctors determine when (and when not) to test for antiglutamate decarboxylase antibodies in patients with neurological disorders and psychiatric symptoms.

Source link

EHS
Back to top button